Johnson & Johnson fined in France for smearing rivals
Credit: flickr/Jamie
France’s competition enforcer has fined Johnson & Johnson subsidiary Janssen-Cilag €25 million after finding the company delayed the availability of low-cost generic versions of one of its painkillers, through both pressure on pharmaceutical regulators and a disparaging and misleading marketing campaign.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now